WANY
RMD icon

Wealthspire Advisors (New York)’s ResMed RMD Stock Holding History

Wealthspire Advisors (New York)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-937
Closed -$226K – 1068
2025
Q4 		$226K Buy
937
+799
+579% +$204K ﹤0.01% 920
2025
Q3 		$37.8K Buy
+138
New +$37.7K ﹤0.01% 1348
2022
Q1 		– Sell
-812
Closed -$212K – 533
2021
Q4 		$212K Sell
812
-81
-9% -$21K ﹤0.01% 511
2021
Q3 		$235K Buy
+893
New +$244K ﹤0.01% 515
2021
Q2 		– Sell
-1,658
Closed -$322K – 599
2021
Q1 		$322K Buy
1,658
+154
+10% +$30.9K 0.01% 529
2020
Q4 		$320K Buy
+1,504
New +$300K 0.01% 420
2020
Q2 		– Sell
-1,749
Closed -$258K – 471
2020
Q1 		$258K Buy
+1,749
New +$279K 0.01% 424
2019
Q1 		– Sell
-14
Closed -$2K – 642
2018
Q4 		$2K Buy
+14
New +$1.5K ﹤0.01% 765

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealthspire Advisors (New York)'s RMD Position: Q1 2026 in Review

Wealthspire Advisors (New York) sold out of ResMed (RMD) in Q1 2026, closing a stake of 937 shares — an estimated $226K sold.

Wealthspire Advisors (New York) first reported a position in RMD in Q4 2018 and held it in 8 quarters. The position peaked at $322K in Q1 2021. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Wealthspire Advisors (New York) reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 937 ResMed shares in Q1 2026, an estimated $226K.
  • Wealthspire Advisors (New York) first reported a position in ResMed in Q4 2018 and held it in 8 quarters.
  • Wealthspire Advisors (New York)'s ResMed position peaked at $322K in Q1 2021.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.